Another way of looking at the efficacy of pralidoxime in organophosphate poisoning.
G
G
Singh
G
G
Avasthi
D000931:Antidotes / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D017408:Guidelines as Topic; D006801:Humans; D062025:Organophosphate Poisoning; D005791:Patient Care / Q000592:standards*; D011041:Poisoning / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D011220:Pralidoxime Compounds / Q000008:administration & dosage*; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000931:Antidotes; D011220:Pralidoxime Compounds; C028797:pralidoxime